Cargando…
Identification and in vivo characterization of a brain-penetrating nanobody
BACKGROUND: Preclinical models to determine blood to brain transport ability of therapeutics are often ambiguous. In this study a method is developed that relies on CNS target-engagement and is able to rank brain-penetrating capacities. This method led to the discovery of an anti-transferrin recepto...
Autores principales: | Wouters, Y, Jaspers, T, De Strooper, B, Dewilde, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556960/ https://www.ncbi.nlm.nih.gov/pubmed/33054787 http://dx.doi.org/10.1186/s12987-020-00226-z |
Ejemplares similares
-
Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics
por: Rué, Laura, et al.
Publicado: (2023) -
Identification and characterization of Nanobodies targeting the EphA4 receptor
por: Schoonaert, Lies, et al.
Publicado: (2017) -
VHHs as tools for therapeutic protein delivery to the central nervous system
por: Wouters, Yessica, et al.
Publicado: (2022) -
Identification and characterization of blocking nanobodies against human CD70: Identification and characterization of blocking nanobodies
por: Zhang, Xin, et al.
Publicado: (2022) -
In vivo SELEX for Identification of Brain-penetrating Aptamers
por: Cheng, Congsheng, et al.
Publicado: (2013)